These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 22924092)
21. Breast carcinogenesis: can the examination of ductal fluid enhance our understanding? Baltzell K; Eder S; Wrensch M Oncol Nurs Forum; 2005 Jan; 32(1):33-9. PubMed ID: 15660141 [TBL] [Abstract][Full Text] [Related]
22. Ductal lavage for detection of cellular atypia in women at high risk for breast cancer. Dooley WC; Ljung BM; Veronesi U; Cazzaniga M; Elledge RM; O'Shaughnessy JA; Kuerer HM; Hung DT; Khan SA; Phillips RF; Ganz PA; Euhus DM; Esserman LJ; Haffty BG; King BL; Kelley MC; Anderson MM; Schmit PJ; Clark RR; Kass FC; Anderson BO; Troyan SL; Arias RD; Quiring JN; Love SM; Page DL; King EB J Natl Cancer Inst; 2001 Nov; 93(21):1624-32. PubMed ID: 11698566 [TBL] [Abstract][Full Text] [Related]
23. Cytomorphology as a risk predictor: experience with fine needle aspiration biopsy, nipple fluid aspiration, and ductal lavage. Masood S Clin Lab Med; 2005 Dec; 25(4):827-43, viii-ix. PubMed ID: 16308095 [TBL] [Abstract][Full Text] [Related]
24. Correlation of cytologic findings and chromosomal instability detected by fluorescence in situ hybridization in breast fine-needle aspiration specimens from women at high risk for breast cancer. Sneige N; Liu B; Yin G; Gong Y; Arun BK Mod Pathol; 2006 May; 19(5):622-9. PubMed ID: 16528376 [TBL] [Abstract][Full Text] [Related]
25. Hypermethylation of the breast cancer-associated gene 1 promoter does not predict cytologic atypia or correlate with surrogate end points of breast cancer risk. Bean GR; Ibarra Drendall C; Goldenberg VK; Baker JC; Troch MM; Paisie C; Wilke LG; Yee L; Marcom PK; Kimler BF; Fabian CJ; Zalles CM; Broadwater G; Scott V; Seewaldt VL Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):50-6. PubMed ID: 17220331 [TBL] [Abstract][Full Text] [Related]
26. Breast ductal lavage for biomarker assessment in high risk women: rationale, design and methodology of a randomized phase II clinical trial with nimesulide, simvastatin and placebo. Lazzeroni M; Guerrieri-Gonzaga A; Serrano D; Cazzaniga M; Mora S; Casadio C; Jemos C; Pizzamiglio M; Cortesi L; Radice D; Bonanni B BMC Cancer; 2012 Dec; 12():575. PubMed ID: 23216985 [TBL] [Abstract][Full Text] [Related]
27. Random periareolar fine-needle aspiration: the new pap smear of the breast? Lester J; Yee LD J Adv Pract Oncol; 2012 Nov; 3(6):411-4. PubMed ID: 25031974 [TBL] [Abstract][Full Text] [Related]
28. Nipple aspiration and ductal lavage in women with a germline BRCA1 or BRCA2 mutation. Mitchell G; Antill YC; Murray W; Kirk J; Salisbury E; Lindeman GJ; Di Iulio J; Milner AD; Devereaux L; Phillips KA Breast Cancer Res; 2005; 7(6):R1122-31. PubMed ID: 16457692 [TBL] [Abstract][Full Text] [Related]
29. Patterns of reduced nipple aspirate fluid production and ductal lavage cellularity in women at high risk for breast cancer. Higgins SA; Matloff ET; Rimm DL; Dziura J; Haffty BG; King BL Breast Cancer Res; 2005; 7(6):R1017-22. PubMed ID: 16280052 [TBL] [Abstract][Full Text] [Related]
30. Evaluation of breast cancer risk assessment techniques: a cost-effectiveness analysis. Ozanne EM; Esserman LJ Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2043-52. PubMed ID: 15598759 [TBL] [Abstract][Full Text] [Related]
31. Digital image analysis of breast epithelial cells collected by random periareolar fine-needle aspirates (RPFNA) from women at high risk for breast cancer taking hormone replacement and the aromatase inhibitor, letrozole, for six months. Frank DH; Kimler BF; Fabian CJ; Ranger-Moore J; Yozwiak M; Bartels HG; Alberts DS; Bartels PH Breast Cancer Res Treat; 2009 Jun; 115(3):661-8. PubMed ID: 19125322 [TBL] [Abstract][Full Text] [Related]
32. Omega-3 and omega-6 Fatty acids in blood and breast tissue of high-risk women and association with atypical cytomorphology. Hidaka BH; Li S; Harvey KE; Carlson SE; Sullivan DK; Kimler BF; Zalles CM; Fabian CJ Cancer Prev Res (Phila); 2015 May; 8(5):359-64. PubMed ID: 25712053 [TBL] [Abstract][Full Text] [Related]
33. Ductal approaches to assessment and management of women at high risk for developing breast cancer. Locke I; Mitchell G; Eeles R Breast Cancer Res; 2004; 6(2):75-81. PubMed ID: 14979910 [TBL] [Abstract][Full Text] [Related]
34. The evolution of breast cancer risk assessment. Hollingsworth AB; Nall S; Dill D J Okla State Med Assoc; 2002 Oct; 95(10):639-44. PubMed ID: 12420413 [TBL] [Abstract][Full Text] [Related]
35. The reliability of nipple aspirate and ductal lavage in women at increased risk for breast cancer--a potential tool for breast cancer risk assessment and biomarker evaluation. Visvanathan K; Santor D; Ali SZ; Brewster A; Arnold A; Armstrong DK; Davidson NE; Helzlsouer KJ Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):950-5. PubMed ID: 17507621 [TBL] [Abstract][Full Text] [Related]
36. Ductal lavage and risk assessment of breast cancer. Arun B Oncologist; 2004; 9(6):599-605. PubMed ID: 15561804 [TBL] [Abstract][Full Text] [Related]
37. Reduction in proliferation with six months of letrozole in women on hormone replacement therapy. Fabian CJ; Kimler BF; Zalles CM; Khan QJ; Mayo MS; Phillips TA; Simonsen M; Metheny T; Petroff BK Breast Cancer Res Treat; 2007 Nov; 106(1):75-84. PubMed ID: 17221152 [TBL] [Abstract][Full Text] [Related]
38. Clinical Trial of Acolbifene in Premenopausal Women at High Risk for Breast Cancer. Fabian CJ; Kimler BF; Zalles CM; Phillips TA; Metheny T; Petroff BK; Havighurst TC; Kim K; Bailey HH; Heckman-Stoddard BM Cancer Prev Res (Phila); 2015 Dec; 8(12):1146-55. PubMed ID: 26391916 [TBL] [Abstract][Full Text] [Related]
39. Ki-67 expression in benign breast ductal cells obtained by random periareolar fine needle aspiration. Bhandare D; Khan SA; Fabian CJ; Khan QJ Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2278; author reply 2278-9. PubMed ID: 16172248 [No Abstract] [Full Text] [Related]
40. Breast cancer risk assessment, prevention, and the future. Green VL Obstet Gynecol Clin North Am; 2013 Sep; 40(3):525-49. PubMed ID: 24021255 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]